I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 23 studies | 32% ± 17% | |
| classical monocyte | 20 studies | 29% ± 12% | |
| macrophage | 19 studies | 34% ± 19% | |
| oligodendrocyte | 16 studies | 43% ± 16% | |
| glutamatergic neuron | 13 studies | 52% ± 27% | |
| monocyte | 11 studies | 31% ± 13% | |
| myeloid cell | 10 studies | 48% ± 19% | |
| mast cell | 10 studies | 44% ± 12% | |
| microglial cell | 9 studies | 25% ± 9% | |
| endothelial cell of lymphatic vessel | 8 studies | 36% ± 16% | |
| GABAergic neuron | 7 studies | 44% ± 20% | |
| astrocyte | 7 studies | 33% ± 11% | |
| dendritic cell | 7 studies | 36% ± 13% | |
| non-classical monocyte | 6 studies | 25% ± 9% | |
| neuron | 6 studies | 35% ± 17% | |
| glial cell | 5 studies | 44% ± 16% | |
| retinal cone cell | 5 studies | 31% ± 10% | |
| adventitial cell | 5 studies | 30% ± 9% | |
| smooth muscle cell | 4 studies | 19% ± 1% | |
| Schwann cell | 4 studies | 61% ± 17% | |
| mononuclear phagocyte | 4 studies | 32% ± 17% | |
| ciliated cell | 4 studies | 22% ± 5% | |
| interneuron | 4 studies | 54% ± 24% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 21% ± 4% | |
| conventional dendritic cell | 3 studies | 26% ± 9% | |
| endothelial cell | 3 studies | 36% ± 16% | |
| retinal pigment epithelial cell | 3 studies | 27% ± 6% | |
| intermediate monocyte | 3 studies | 36% ± 22% | |
| alveolar macrophage | 3 studies | 32% ± 7% | |
| natural killer cell | 3 studies | 19% ± 3% | |
| granule cell | 3 studies | 36% ± 7% |
